Evidence map›Paper›PMID 27543265›Full record

ArticleMolecular and cellular endocrinology2016

Estrogen receptor-α and aryl hydrocarbon receptor involvement in the actions of botanical estrogens in target cells.

Ping Gong, Zeynep Madak-Erdogan, Jodi A Flaws, David J Shapiro, John A Katzenellenbogen, Benita S Katzenellenbogen

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular endocrinology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Multi-Anticancer Activities of Phytoestrogens in Human Osteosarcoma.International journal of molecular sciences · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. A Network Pharmacology Approach for Uncovering the Osteogenic Mechanisms ofEvidence-based complementary and alternative medicine : eCAM · 2019
    Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ping GongDepartment of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Zeynep Madak-ErdoganDepartment of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Jodi A FlawsDepartment of Comparative Biosciences, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
David J ShapiroDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
John A KatzenellenbogenDepartment of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Benita S KatzenellenbogenDepartment of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA. Electronic address: katzenel@illinois.edu.
University of Illinois Urbana-Champaign · US

Funding

Pharmacokinetics, Bioavailability, and Metabolism/Daniel R. DoergeP50AT006268 · NCCIH · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI HELFERICH, WILLIAM G · 2010 to 2015
$7.6M
MOLECULAR PROBES FOR STEROID RECEPTORSR37DK015556 · NIDDK · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI KATZENELLENBOGEN, JOHN A. · 1987 to 2012
$4.4M
Targeting Breast Cancer with Small Molecule Inhibitors of Estrogen ReceptorR01DK071909 · NIDDK · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI SHAPIRO, DAVID J · 2005 to 2020
$4.3M
Novel Ligands and Mechanisms to Achieve Selective Nuclear Receptor ActivityR01DK015556 · NIDDK · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI KATZENELLENBOGEN, JOHN A. · 1986 to 2016
$1.6M
NCCIH NIH HHS P50 AT006268NIDDK NIH HHS R01 DK015556NIDDK NIH HHS R01 DK071909NIDDK NIH HHS R37 DK015556
6 · The paper itself

Abstract

Botanical estrogen (BE) dietary supplements are consumed by women as substitutes for loss of endogenous estrogens at menopause. To examine the roles of estrogen receptor α (ERα) and aryl hydrocarbon receptor (AhR) and their crosstalk in the actions of BEs, we studied gene regulation and proliferation responses to four widely used BEs, genistein, daidzein, and S-equol from soy, and liquiritigen from licorice root in breast cancer and liver cells. BEs and estradiol (E2), acting through ERα, stimulated proliferation, ERα chromatin binding and target-gene expression. BEs but not E2, acting through AhR, bound to xenobiotic response element-containing chromatin sites and enhanced AhR target-gene expression (CYP1A1, CYP1B1). While E2 and TCDD acted quite selectively through their respective receptors, BEs acted via both receptors, with their AhR activity moderated by negative crosstalk through ERα. Both ERα and AhR should be considered as mediators of the biology and pharmacology of BEs.

Indexed as

Binding SitesBreast NeoplasmsCell ProliferationChromatinCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1Dose-Response Relationship, DrugEstradiolEstrogen Receptor alphaEstrogensFemaleGene Expression Regulation, NeoplasticGene Knockdown TechniquesHep G2 CellsHumansMCF-7 CellsChromatinCYP1A1 protein, humanCYP1B1 protein, humanCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1ESR1 protein, humanEstradiolEstrogen Receptor alphaEstrogensPolychlorinated DibenzodioxinsReceptors, Aryl HydrocarbonReceptors, ProgesteroneRNA, Small InterferingAryl hydrocarbon receptorBotanical estrogensCell proliferationEstrogen receptorGene regulationXenobiotic metabolism

Identifiers

PMID27543265
PMCPMC5873581
OpenAlexW2512728364

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.